Subscribe
Subscribe
华海药业
Huahaipharm especially in the field of cardiovascular Puri and Sartan drugs'
Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is a pharmaceutical company integrating pharmaceutical preparations and APIs. The company is a leading enterprise in the domestic specialty API industry, especially in the field of cardiovascular Puri and Sartan drugs, the company has the core technology and is currently the largest supplier of Puri and Sartan drugs in the world with the largest number of production varieties and leading technical level.
Huahaipharm especially in the field of cardiovascular Puri and Sartan drugs'
Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is a pharmaceutical company integrating pharmaceutical preparations and APIs. The company is a leading enterprise in the domestic specialty API industry, especially in the field of cardiovascular Puri and Sartan drugs, the company has the core technology and is currently the largest supplier of Puri and Sartan drugs in the world with the largest number of production varieties and leading technical level.
Neusoft Medical Launches Ten New Products and Online Shopping Mall
Realcan's Digital Healthcare Branch Launches New Service Platform
3D Medicines Diagnosis Raises CNY 1.5 Bn after Being Spun-off
Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn
Varian Medical Strikes CIIE with Digital Solution for Oncology
GeneMind Biotech Closes Series B of CNY 140 Mn
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
China's NMPA Reduces Paperwork for Inland Producers to Make Exotic Medical Devices
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Tongshu Gene Closes Series B of Multi-Hundreds Millions
Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
JD Health’s New Move on Hong Kong IPO
Biotech IMAB’s In-Process New Drug Enters Clinical Trials
3D Printing Precision Medicine Industry Park Lands in Hunan
Antibody Developer Biocytogen Closes Series D+ at CNY 790 Mn
Edge Medical Robotics Closes Pre Series B at Over CNY 100 Mn
Nasdaq-listed Biotech ZLAB Passes the Hearing for Hong Kong IPO
Genor Biopharma Passes the Hearing for Hong Kong IPO
EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.
We strive to make technology inclusive, accessible and transparent.
Join over 70,000 of your peers
Beijing
9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai
A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China
New York
800 Third Ave, 28F, New York, NY 10022, USA
Cooperation strategy
Products & prices
Customers & evaluation
